tiprankstipranks
Trending News
More News >
Sarepta Therapeutics (SRPT)
NASDAQ:SRPT
US Market

Sarepta Therapeutics (SRPT) Cash flow

Compare
4,043 Followers

Sarepta Therapeutics Cash Flow

SRPT's free cash flow for Q3 2025 was $0.00. For the 2025 fiscal year, SRPT's free cash flow was decreased by $245.59M and operating cash flow was $0.00. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -205.79M$ -500.99M$ -325.35M$ -443.17M$ 107.47M
Investing Cash Flow
$ 755.56M$ -165.80M$ -1.05B$ 495.41M$ -121.72M
Financing Cash Flow
$ 124.81M$ 125.00M$ 232.51M$ 561.57M$ 682.32M
End Cash Position
$ 1.12B$ 444.01M$ 985.80M$ 2.13B$ 1.51B
Free Cash Flow
$ -342.74M$ -588.34M$ -357.60M$ -481.66M$ 25.26M
Currency in USD

Sarepta Therapeutics Cash Flow